The principal objective is to strengthen capacities of institutions to support safety and efficacy studies in Phase II and III trials on HIV/AIDS and malaria (drugs and/or vaccines) and to initiate/develop clinical research activities on Tuberculosis.

The strategic objectives are to:

  • Develop human resources in the skills required to conduct safe clinical trials including GCP/GLP training and preparation and development of clinical and standardized protocols from recruitment of participants to the conduct of clinical trials
  • Strengthen laboratories to be able to perform relevant tests for HIV/AIDS and malaria clinical research
  • Strengthen ethical review boards and regulatory authorities in needy collaborating sites
  • Establish effective community liaison at each site and identify new study cohorts in rural and urban areas for future clinical trials on HIV/AIDS and malaria.